ormal temporal contrast sensitivity and retinal illuminance
Withdrawn
- Conditions
- neuronal disordersretinal disorders10047518
- Registration Number
- NL-OMON35452
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
normal healthy eyes without any history of ocular disease
Exclusion Criteria
any presence or history of ocular pathologies or other disorders, especially retinal and/or neuronal disorders
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary study parameter is the measured temporal contrast sensitivity value</p><br>
- Secondary Outcome Measures
Name Time Method <p>N/A</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie temporal contrast sensitivity deficits in retinal disorders like age-related macular degeneration?
How does non-invasive retinal illuminance assessment compare to standard-of-care diagnostics for neuronal visual pathway disorders?
Which biomarkers predict variability in temporal contrast sensitivity outcomes among patients with retinal degenerative diseases?
What adverse events are associated with prolonged retinal illuminance measurements in observational ophthalmology studies?
Are there combination therapies involving neuroprotectants and retinal prosthetics that improve contrast sensitivity in glaucoma or optic neuropathy?